GLPG0974

DRUG3 trials

Sponsors

Galapagos NV

Conditions

HealthyUlcerative Colitis

Phase 1

First-in-Human Exploratory Single Ascending Dose of GLPG0974

CompletedNCT01496937

Galapagos NVHealthy

Start: 2011-12-31End: 2012-02-29Updated: 2012-04-19

Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects

CompletedNCT01721980

Galapagos NVHealthy

Start: 2012-10-31End: 2013-02-28Updated: 2013-02-12

Phase 2

Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis

CompletedNCT01829321

Galapagos NVUlcerative Colitis

Start: 2013-04-30End: 2014-04-30Updated: 2014-04-25